About Us
Founded in 2008 as Nanobacterie, AlphaOnco leads the field of magnetic nanoparticle-based cancer therapies. With over 15 years of groundbreaking research, we’ve transitioned from proof-of-concept experiments to near clinical application. Our journey reflects unwavering dedication to combating cancer with innovation and collaboration.
Our Solution
We have developed an innovative treatment called magnetic hyperthermia. By leveraging magnetosomes, naturally occurring magnetic nanoparticles, we introduce a safer, more targeted method to combat tumors.
Our Pipeline
We at AlphaOnco, Focus on applying magnetic hyperthermia for glioblastoma, an incurable and aggressive form of brain cancer
Collaborations
Our collaborative network includes world-renowned academic and medical organizations, ensuring that our innovative magnetosome-based therapies are backed by rigorous research and clinical expertise. Together, we’re advancing the boundaries of oncology to offer new hope where it’s needed most.
Subsribe To Our Newsletter
Stay in touch with us to get latest news.